CJC-1295 no DAC - 5mg x 10 vial kit

$130.00 USD

10 vials of 5mg each.

Important: For laboratory and research use only. Not for human consumption.

Under no circumstances should any products be used without the express direction of a licensed physician.

Description

A kit of 10 vials of CJC-1295 no DAC. Each vial contains 5mg of lyophilized CJC-1295 no DAC.

CJC-1295 no DAC, more accurately called Modified GRF(1-29), is a short-acting analogue of growth hormone-releasing hormone, or GHRH. It binds GHRH receptors in the pituitary and stimulates release of endogenous growth hormone. Unlike the long-acting DAC version, it does not bind albumin and is cleared relatively quickly, so its effect is intended to resemble a brief GH pulse rather than sustained stimulation.

Potential benefits suggested by its mechanism include increased pulsatile GH release, higher downstream IGF-1 signaling, improved recovery, changes in body composition, enhanced fat metabolism, and possible effects on sleep and tissue repair. One reason researchers are interested in the no-DAC form is that normal growth hormone secretion is naturally pulsatile. A short-acting GHRH agonist can provide a transient pituitary stimulus and then clear, theoretically preserving a more physiological secretion pattern than continuously elevated GHRH activity.

It is also commonly paired experimentally with a ghrelin-receptor agonist such as ipamorelin because the two stimulate GH secretion through different pathways -- GHRH receptor signaling and GHSR-1a signaling.